Ion mobility mass spectrometry for peptide analysis
The approval is based on data from the randomized, open-label Phase III PAPILLON trial that showed the Rybrevant-based regimen cut the risk of disease progression or death by 60% versus chemotherapy alone
Brown-Vialetto-Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment
GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy, Rybelsus) have significantly improved the management of obesity and type 2 diabetes, providing effective weight loss and cardiometabolic benefits
Virgie Tovar: Yes, I think Stephanie brings up an interesting point around nutrition
Intracellular redistribution of acetyl-CoA, the pivotal point in differential susceptibility of cholinergic neurons and glial cells to neurodegenerative signals